Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01ZJK
|
||||
Former ID |
DAP000428
|
||||
Drug Name |
Ardeparin
|
||||
Synonyms |
Arteven; Bemiparin; Certoparin; Clivarin; Clivarine; Dalteparin; Eparina; Fluxum; Fraxiparin; Heparin; Heparina; Heparinate; Heparine; Heparinum; Hepathrom; Innohep; Liquaemin; Liquemin; Logiparin; Multiparin; Nadroparin; Nadroparine; Novoheparin; Octaparin; Pabyrin; Panheprin; Parnaparin; Parvoparin; Pularin; Reviparin; Sandoparin; Subeparin; Sublingula; Thromboliquine; Tinzaparin; Triofiban; Vetren; Allocinnamic acid; Ardeparin sodium; Bemiparin sodium; Dalteparin sodium; Enoxaparin sodium; Eparina [DCIT]; Fragmin A; Fragmin B; Fragmin IV; Hep Flush Kit in plastic container; Heparin Lock Flush; Heparin Lock Flush in plastic container; Heparin Lock Flush preservative free; Heparin Lock Flush preservative free in plastic container; Heparin natrium; Heparin sodium; Heparin sodium in plastic container; Heparin sodium preservative Free; Heparin sulfate; Heparinic acid; Heparinum natricum; Isocinnamic acid; Liquaemin Lock Flush; Liquaemin Sodium; Liquaemin sodium preservative free; Minolteparin sodium; Parnaparin sodium; Reviparin sodium; Sodium acid heparin; Sodium heparin; Sodium heparinate; Tinzaparin sodium; Vitrum AB; CY 216; Cy 222; FR 860; H 2149; Heparin CY 216; KB 101; Kabi 2165; LHN 1; Lioton 1000; OP 386; OP 622; Ro 11; WY 90493RD; ALFA 87-120; ALFA 87-163; ALFA 87-198; ALFA 87-81; ALFA 88-247; Alpha-Heparin; Cis-Cinnamic acid; Depo-Heparin; Hed-heparin; Hep-Lock; Heparin, sodium salt; Heparina [INN-Spanish]; Heparine [INN-French]; Heparinum [INN-Latin]; Hepflush-10; Inno-Hep; Lipo-hepin; Normiflo (TN); Hep-Lock U/P; Heparin sodium 1,000 units in dextrose 5% in plastic container; Heparin sodium 10,000 units in dextrose 5%; Heparin sodium 10,000 units in dextrose 5%in plastic container; Heparin sodium 12,500 units in dextrose 5%; Heparin sodium 12,500 units in dextrose 5% in plastic container; Heparin sodium 2,000 units in dextrose 5% in plastic container; Heparin sodium 20,000 units and dextrose 5% in plastic container; Heparin sodium 20,000 units in dextrose 5% in plastic container; Heparin sodium 25,000 units and dextrose 5% in plastic container; Heparinsodium 25,000 units in dextrose 5%; Heparin sodium 25,000 units in dextrose 5% in plastic container; Heparin sodium 5,000 units in dextrose 5% in plastic container; Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container; Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container; Heparin sodium 10,000 units in sodium chloride 0.45%; Heparin sodium 10,000 units in sodium chloride 0.9%; Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container; Heparin sodium 12,500 units in sodium chloride 0.9%; Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container; Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container; Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container; Heparin sodium 25,000 units insodium chloride 0.9%; Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container; Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container; Heparin sodium 5,000 units insodium chloride 0.45%; Heparin sodium 5,000 units in sodium chloride 0.9%; Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container; Cis-.beta.-Carboxystyrene
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Deep vein thrombosis [ICD9: 437.6, 453, 453.40, 671.5, 671.9; ICD10:I80-I82, I80.2] | Approved | [536110] | ||
Therapeutic Class |
Anticoagulants
|
||||
Company |
Celcius Laboratories
|
||||
Structure |
Download2D MOL |
||||
Formula |
C9H8O2
|
||||
Canonical SMILES |
C1=CC=C(C=C1)C=CC(=O)O
|
||||
InChI |
1S/C9H8O2/c10-9(11)7-6-8-4-2-1-3-5-8/h1-7H,(H,10,11)
|
||||
InChIKey |
WBYWAXJHAXSJNI-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 9005-49-6
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
6535120, 8156229, 10530334, 29227437, 51073550, 57325241, 80708216, 85084882, 85086575, 91105364, 104318751, 125340739, 125363823, 126676137, 127270292, 127270293, 127270294, 127270295, 127270296, 127270297, 127270298, 127270299, 127270300, 127270301, 127270302, 127270303, 127270304, 127270305, 127270306, 127270307, 127270308, 127270309, 127270310, 127270311, 127270312, 127270313, 127270314, 127270315, 127270316, 127270317, 127270318, 127270319, 127270320, 127270321, 127270322, 127270323, 127270324, 127270325, 127270326, 127270327
|
||||
ChEBI ID |
ChEBI:28304
|
||||
SuperDrug ATC ID |
B01AB01; B01AB01; B01AB01; B01AB04; B01AB05; B01AB05; B01AB06; B01AB07; B01AB07; B01AB08; B01AB10; B01AB12; C05BA03; C05BA03; C05BA03; S01XA14
|
||||
Target and Pathway | |||||
Target(s) | Antithrombin-III | Target Info | Modulator | [556264] | |
KEGG Pathway | Complement and coagulation cascades | ||||
PANTHER Pathway | Blood coagulation | ||||
Pathway Interaction Database | Glypican 1 network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.